You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

reduced-toxicity conditioning

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)

Not yet recruiting
  • Stem Cell Transplantation
  • Houston, Texas
    M D Anderson Cancer Center
May 4, 2022

Thalassemia in Children Trial in Toronto (Abatacept, Sirolimus)

Recruiting
  • Thalassemia in Children
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Jun 19, 2022

Leukemia Trial (90-Yttrium-labelled anti-CD66 mAb)

Not yet recruiting
  • Leukemia
  • 90-Yttrium-labelled anti-CD66 monoclonal antibody
  • (no location specified)
Aug 16, 2022

Sickle Cell Disease, Umbilical Cord Blood, Hematopoietic Cell Proliferation Trial in Palo Alto, San Francisco (ECT-001-CB

Withdrawn
  • Sickle Cell Disease
  • +2 more
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • Palo Alto, California
  • +1 more
Jun 29, 2022

Refractory Acute Myeloid Leukemia Trial in Shanghai (Aza-Ven-allo-HSCT)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • Shanghai, China
  • +2 more
May 27, 2021

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Morgantown (Busulfan, Fludarabine)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Morgantown, West Virginia
    West Virginia University Hospitals Mary Babb Randolph Cancer Cen
Apr 6, 2021

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)

Recruiting
  • Refractory Leukemia
  • CALGE-VEN- RIC-MBF
  • Shanghai, Shanghai, China
  • +2 more
May 22, 2023

Anal Cancer Trial in Cincinnati (Radiation (reduced elective nodal dose (30.6 Gy), Capecitabine, Mitomycin c)

Not yet recruiting
  • Anal Cancer
  • Radiation (reduced elective nodal dose (30.6 Gy)
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Jun 5, 2023

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)

Recruiting
  • Hematological Malignancy
  • Multiple Myeloma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022

Patients Receiving Mismatched Allogeneic HCT Trial in Germany (immunosuppression)

Terminated
  • Patients Receiving Mismatched Allogeneic HCT
  • Mainz, Germany
  • +3 more
Jun 29, 2022

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity

Not yet recruiting
  • Nasopharyngeal Carcinoma
    • Fuzhou, Fujian, China
      Department of radiation oncology, Fujian cancer hospital
    Nov 16, 2023

    Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

    Recruiting
    • Non Malignant Diseases
    • +2 more
    • RIC: Distal Campath
    • +2 more
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Mar 8, 2022

    Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Brentuximab Vedotin
    • +2 more
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

    Recruiting
    • Hematologic Malignancies
    • Haplo HCT <55 years old
    • +4 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 25, 2023

    Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute

    Not yet recruiting
    • Peripheral Blood Stem Cell Transplantation
    • Hematopoietic Stem Cell Transplantation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Jan 25, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +17 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 10, 2023

    Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

    Active, not recruiting
    • Acute Leukemia
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Chronic Lymphocytic Leukemia Trial in Spain (Ofatumumab)

    Completed
    • Chronic Lymphocytic Leukemia
    • Badalona, Spain
    • +8 more
    May 2, 2022

    Disease-free Survival Trial in Shanghai (MBF-RIC)

    Recruiting
    • Disease-free Survival
    • Shanghai, Shanghai, China
    • +1 more
    Jun 28, 2022

    Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,

    Recruiting
    • Severe Sickle Cell Disease
    • +5 more
    • RIC regimen
    • GVHD prophylaxis regimen
    • New Haven, Connecticut
    • +1 more
    Feb 4, 2022